Roche: HY 2014 Results (Roche) - Jul 26, 2014 - Anticipated NME submission in EU for hematological tumors in 2017 or later; Anticipated NME submission in US for hematological tumors in 2017 or later
Anticipated EU regulatory • Anticipated NDA • Oncology
|